A drug is injected into the inner ear. The drug, investigational gene therapy DB-OTO, is attached to a virus which delivers the DB-OTO to the cells and the virus is then ejected by the response of the body. In about four weeks the patients begin to hear. After about seven months their hearing is just about normal..

Views: 4